EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieQuerschnittstudieOpen Access

The MindMoves Trial: Cross-Sectional Analyses of Baseline Vascular Risk and Cognition in Older Women with Cardiovascular Disease

Shannon Halloway, Annabelle Santos Volgman, Lisa L Barnes, Michael E Schoeny, JoEllen Wilbur, Susan J Pressler, Deepika Laddu, Shane A Phillips, Sachin Vispute, Gabriel Hall, Shamatree Shakya, Madison Goodyke und 4 weitere

Journal of Alzheimer’s Disease · 2024

DOI: 10.3233/jad-240100 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Journal of Alzheimer’s Disease, 2024. Verfasst von Shannon Halloway und 15 weiteren Autor:innen. Beteiligte Einrichtung: College of Nursing, University of Illinois Chicago, Chicago, IL, USA. Hauptthemen laut MEDLINE: Cardiovascular Diseases, Biomarkers, Cognition, Insulin-Like Growth Factor I. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NINR NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Vascular diseases, including atherosclerotic cardiovascular disease (ASCVD) and stroke, increase the risk of Alzheimer’s disease and cognitive impairment. Serum biomarkers, such as brain-derived neurotrophic factor (BDNF), vascular endothelial growth factor (VEGF), and insulin-like growth factor 1 (IGF-1), may be indicators of cognitive health.

Objective

We examined whether vascular risk was associated with levels of cognition and serum biomarkers in older women with cardiovascular disease (CVD).

Methods

Baseline data from a lifestyle trial in older women ( n = 253) with CVD (NCT04556305) were analyzed. Vascular risk scores were calculated for ASCVD (ASCVD risk estimator) and stroke (CHA 2 DS 2 -VASc) based on published criteria. Cognition-related serum biomarkers included BDNF, VEGF, and IGF-1. Cognition was based on a battery of neuropsychological tests that assessed episodic memory, semantic memory, working memory, and executive function. A series of separate linear regression models were used to evaluate associations of vascular risk scores with outcomes of cognition and serum biomarkers. All models were adjusted for age, education level, and racial and ethnic background.

Results

In separate linear regression models, both ASCVD and CHA 2 DS 2 -VASc scores were inversely associated with semantic memory (β= –0.22, p = 0.007 and β= –0.15, p = 0.022, respectively), with no significant findings for the other cognitive domains. There were no significant associations between vascular risk scores and serum biomarkers.

Conclusions

Future studies should prospectively examine associations between vascular risk and cognition in other populations and additionally consider other serum biomarkers that may be related to vascular risk and cognition.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cardiovascular DiseasesBiomarkersCognitionInsulin-Like Growth Factor IHumansFemaleAgedCross-Sectional StudiesNeuropsychological TestsBrain-Derived Neurotrophic FactorVascular Endothelial Growth Factor ACognitive DysfunctionRisk FactorsMiddle Aged

Stichwörter der Autor:innen

Alzheimer’s diseasebiomarkerscardiovascular healthrisk factorsstroke

Substanzen

BiomarkersInsulin-Like Growth Factor IBrain-Derived Neurotrophic FactorVascular Endothelial Growth Factor A

Autor:innen und Institutionen

  • College of Nursing, University of Illinois Chicago, Chicago, IL, USA.
  • Rush Medical College, Rush University, Chicago, IL, USA.
  • Rush Alzheimer's Disease Center, Rush University Medical Center, Chicago, IL, USA.
  • Rush University College of Nursing, Rush University, Chicago, IL, USA.
  • Indiana University School of Nursing, Indiana University, IN, USA.
  • Arbor Research Collaborative for Health, Ann Arbor, MI, USA.

Förderung

  • NINR NIH HHS

Zitieren

APA

Halloway, S., Volgman, A. S., Barnes, L. L., Schoeny, M. E., Wilbur, J., Pressler, S. J., Laddu, D., Phillips, S. A., Vispute, S., Hall, G., Shakya, S., Goodyke, M., Auger, C., Cagin, K., Borgia, J. A., & Arvanitakis, Z. A. (2024). The MindMoves Trial: Cross-Sectional Analyses of Baseline Vascular Risk and Cognition in Older Women with Cardiovascular Disease. Journal of Alzheimer’s Disease. https://doi.org/10.3233/jad-240100

Vancouver

Halloway S, Volgman AS, Barnes LL, Schoeny ME, Wilbur J, Pressler SJ, et al. The MindMoves Trial: Cross-Sectional Analyses of Baseline Vascular Risk and Cognition in Older Women with Cardiovascular Disease. Journal of Alzheimer’s Disease. 2024. doi:10.3233/jad-240100

BibTeX
@article{Halloway2024,
  author = {Halloway, Shannon and Volgman, Annabelle Santos and Barnes, Lisa L and Schoeny, Michael E and Wilbur, JoEllen and Pressler, Susan J and Laddu, Deepika and Phillips, Shane A and Vispute, Sachin and Hall, Gabriel and Shakya, Shamatree and Goodyke, Madison and Auger, Claire and Cagin, Kelly and Borgia, Jeffrey A and Arvanitakis, Zoe A},
  title = {The MindMoves Trial: Cross-Sectional Analyses of Baseline Vascular Risk and Cognition in Older Women with Cardiovascular Disease},
  journal = {Journal of Alzheimer’s Disease},
  year = {2024},
  doi = {10.3233/jad-240100}
}
Kostenlos starten →